BTIG Maintains Their Buy Rating on Acutus Medical (AFIB)
alphanewsstream
2021-05-13 02:00
BTIG Maintains Their Buy Rating on Acutus Medical (AFIB)
In a report released yesterday, Marie Thibault from BTIG maintained a Buy rating on Acutus Medical (AFIB), with a price target of $26.00.
The post BTIG Maintains Their Buy Rating on Acutus Medical (AFIB) appeared first on Smarter Analyst.
In a report released yesterday, Marie Thibault from BTIG ...

https://www.smarteranalyst.com/new-blurbs/btig-maintains-their-buy-rating-on-acutus-medical-afib-2/

#SmarterAnalyst
Piilota kommentit Kommentit (0)

Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.